Related Experiment Video
Updated: May 18, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
[Parkinson's disease: current standards in diagnostics and therapy].
L Timmermann1, C Eggers, H Salimi Dafsari
1Klinik und Poliklinik für Neurologie, Universitätsklinikum Köln. lars.timmermann@uk-koeln.de
Fortschritte Der Neurologie-Psychiatrie
|October 4, 2012
Summary
Early Parkinson's disease diagnosis is improving with advanced imaging, aiding differentiation from atypical syndromes. Treatment focuses on symptom control and disease modification, with advanced therapies like pump systems and deep brain stimulation offering options for later stages.
Area of Science:
- Neurology
- Medical Imaging
- Nuclear Medicine
Context:
- Idiopathic Parkinson's disease diagnosis remains clinical.
- Advanced imaging and nuclear techniques enhance early diagnosis.
- Differential diagnosis between idiopathic and atypical Parkinson syndromes is improving.
Purpose:
- To review current diagnostic and therapeutic strategies for Parkinson's disease.
- To highlight the role of modern imaging in early and differential diagnosis.
- To discuss treatment options at different disease stages.
Summary:
- Early stages emphasize disease progression modification and symptom control.
- Continuous dopaminergic stimulation is crucial for later stages with fluctuations.
- Advanced therapies include Duodopa, apomorphine pump therapies, and subthalamic nucleus deep brain stimulation.
Impact:
- Improved diagnostic accuracy for Parkinson's disease.
- Enhanced therapeutic strategies for symptom management and disease modification.
- Subthalamic nucleus deep brain stimulation offers a successful option for select patients.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...